TyphaneosideCAS# 104472-68-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 104472-68-6 | SDF | Download SDF |
PubChem ID | 5489389 | Appearance | Light yellow powder |
Formula | C34H42O20 | M.Wt | 770.69 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | Isorhamnetin 3-(2''-rhamnosylrutinoside); 3,4',5,7-Tetrahydroxy 3'-methoxyflavone 3-(2''-rhamnosylrutinoside) | ||
Solubility | Soluble in ethanol, methanol and pyridine | ||
Chemical Name | 3-[(3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one | ||
SMILES | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)OC6C(C(C(C(O6)C)O)O)O)O)O)O)O)O | ||
Standard InChIKey | POMAQDQEVHXLGT-QQVXUORWSA-N | ||
Standard InChI | InChI=1S/C34H42O20/c1-10-20(38)24(42)27(45)32(49-10)48-9-18-22(40)26(44)31(54-33-28(46)25(43)21(39)11(2)50-33)34(52-18)53-30-23(41)19-15(37)7-13(35)8-17(19)51-29(30)12-4-5-14(36)16(6-12)47-3/h4-8,10-11,18,20-22,24-28,31-40,42-46H,9H2,1-3H3/t10-,11-,18+,20-,21-,22+,24+,25+,26-,27+,28+,31+,32+,33-,34?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Typhaneoside is possibly the main active component in the bioactive fraction of Shaofu Zhuyu decoction, Shaofu Zhuyu decoction may have direct inhibitory effects on the contractility of the mice uterus. It has an inhibitory effect on the proliferation of human umbilical arterial smooth muscle cells(HUASMC) with a wide range of effective dose but the effect is started slowly. |
In vitro | Influence of typhaneoside on proliferation of human umbilical arterial smooth muscle cells.[Reference: WebLink]Journal of Beijing University of Traditional Chinese Medicine, 2006, 29(5):307-10.To study the influence of Typhaneoside on the proliferation of human umbilical arterial smooth muscle cells(HUASMC). |
In vivo | Inhibitory effects of active fraction and its main components of Shaofu Zhuyu decoction on uterus contraction.[Pubmed: 20626062]Am J Chin Med. 2010;38(4):777-87.Shaofu Zhuyu decoction is a famous formula for treating primary dysmenorrhea in China since the Qing dynasty. In this paper, the inhibitory effects of active-guided fraction and its main bioactive components of Shaofu Zhuyu decoction on a model of non-pregnant mice uterine contraction induced by oxytocin in vitro were investigated. |
Structure Identification | J Pharm Biomed Anal. 2012 Nov;70:636-9.Determination of typhaneoside in rat plasma by liquid chromatography-tandem mass spectrometry.[Pubmed: 22818028]
|
Typhaneoside Dilution Calculator
Typhaneoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.2975 mL | 6.4877 mL | 12.9754 mL | 25.9508 mL | 32.4385 mL |
5 mM | 0.2595 mL | 1.2975 mL | 2.5951 mL | 5.1902 mL | 6.4877 mL |
10 mM | 0.1298 mL | 0.6488 mL | 1.2975 mL | 2.5951 mL | 3.2438 mL |
50 mM | 0.026 mL | 0.1298 mL | 0.2595 mL | 0.519 mL | 0.6488 mL |
100 mM | 0.013 mL | 0.0649 mL | 0.1298 mL | 0.2595 mL | 0.3244 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- L803-mts
Catalog No.:BCC5889
CAS No.:1043881-55-5
- RU-SKI 43
Catalog No.:BCC5441
CAS No.:1043797-53-0
- Tetrahydroxysqualene
Catalog No.:BCN5858
CAS No.:1043629-23-7
- Bisoprolol fumarate
Catalog No.:BCC4344
CAS No.:104344-23-2
- IRAK inhibitor 6
Catalog No.:BCC1658
CAS No.:1042672-97-8
- Famciclovir
Catalog No.:BCC4780
CAS No.:104227-87-4
- IRAK inhibitor 1
Catalog No.:BCC1654
CAS No.:1042224-63-4
- Yunnandaphninine G
Catalog No.:BCN5857
CAS No.:1042143-83-8
- Estriol 3,17-dihexanoate
Catalog No.:BCN2238
CAS No.:104202-96-2
- 10-Nitro-camptothecin
Catalog No.:BCN2581
CAS No.:104195-61-1
- Stanozolol
Catalog No.:BCC9154
CAS No.:10418-03-8
- Alpinoid D
Catalog No.:BCN3593
CAS No.:1041740-13-9
- 3'-Methylflavokawin
Catalog No.:BCN3990
CAS No.:1044743-35-2
- RVX-208
Catalog No.:BCC4475
CAS No.:1044870-39-4
- Testosterone acetate
Catalog No.:BCC9165
CAS No.:1045-69-8
- Bayogenin 3-O-beta-D-glucopyranoside
Catalog No.:BCN7868
CAS No.:104513-86-2
- EC 23
Catalog No.:BCC6097
CAS No.:104561-41-3
- CAY10603
Catalog No.:BCC5542
CAS No.:1045792-66-2
- p-Menthan-3-one
Catalog No.:BCN3850
CAS No.:10458-14-7
- Caffeic acid phenethyl ester
Catalog No.:BCN2695
CAS No.:104594-70-9
- CGS 15943
Catalog No.:BCC7157
CAS No.:104615-18-1
- Pramipexole dihydrochloride
Catalog No.:BCN2181
CAS No.:104632-25-9
- Pramipexole
Catalog No.:BCC4467
CAS No.:104632-26-0
- Dexpramipexole dihydrochloride
Catalog No.:BCC1528
CAS No.:104632-27-1
Determination of typhaneoside in rat plasma by liquid chromatography-tandem mass spectrometry.[Pubmed:22818028]
J Pharm Biomed Anal. 2012 Nov;70:636-9.
A highly sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for the determination of Typhaneoside in rat plasma using rutin as internal standard. The analyte and rutin (internal standard) were extracted with methanol followed by a rapid isocratic elution with 10 mM ammonium acetate buffer/methanol (v:v, 20:80) on an C(18) column (150 mm x 2.1 mm I.D.) and subsequent analysis by mass spectrometry in the multi-reaction-monitoring mode. The precursor to product ion transitions of m/z 769.3 --> 314.1 and m/z 609.2 --> 300.1 were used to measure the analyte and the internal standard. The assay was linear over the concentration range of 0.01-10 mug/mL for Typhaneoside in rat plasma. The lower limit of quantification was 0.01 mug/mL and the extraction recovery was larger than 90.2% for Typhaneoside. The inter- and intra-day precision of the method at three concentrations was less than 6.8%. The method was firstly applied to pharmacokinetic study of Typhaneoside in rats.
Inhibitory effects of active fraction and its main components of Shaofu Zhuyu decoction on uterus contraction.[Pubmed:20626062]
Am J Chin Med. 2010;38(4):777-87.
Shaofu Zhuyu decoction is a famous formula for treating primary dysmenorrhea in China since the Qing dynasty. In this paper, the inhibitory effects of active-guided fraction and its main bioactive components of Shaofu Zhuyu decoction on a model of non-pregnant mice uterine contraction induced by oxytocin in vitro were investigated. Qualitative and quantitative chemical analyses were used to correlate the chemical composition of active fraction with the spasmolytic effects. Seven ingredients in the active fraction were identified and quantified by HPLC-DAD. Three ingredients, ferulic acid, vanillic acid, and Typhaneoside, were evaluated for their effects on mice isolated uterine contraction induced by oxytocin in vitro. The ED(50) of them were 63.0 microg/ml, 57.6 microg/ml, 109.7 microg/ml, respectively. Furthermore, the inhibitory activity of the combination of these three compounds was prior to the fraction and seven compounds group. The ED(50) was 65.5 microg/ml. The data stated that ferulic acid, vanillic acid, and Typhaneoside were possibly the main active components in the bioactive fraction of Shaofu Zhuyu decoction. The study also implied that Shaofu Zhuyu decoction may have direct inhibitory effects on the contractility of the mice uterus and justified the traditional use of the prescription for treating the uterine cramping associated dysmenorrhea.